{
    "organizations": [],
    "uuid": "f0c24b11f525854ab9fe058a2a65091c0b4a2d94",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/health-asacol/allergan-loses-bid-to-avoid-asacol-antitrust-trial-after-appellate-order-idUSL1N1PE1YC",
    "ord_in_thread": 0,
    "title": "Allergan loses bid to avoid Asacol antitrust trial after appellate order",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Allergan PLC on Friday lost a last-minute bid to delay an upcoming trial in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.\nU.S. District Judge Denise Casper in Boston denied Allerganâ€™s request to stay the case pending its appeal of her November 2017 decision to certify a class of health plans and other indirect purchasers of the drugs.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2DPH3to\n ",
    "published": "2018-01-20T06:06:00.000+02:00",
    "crawled": "2018-01-20T03:10:21.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "allergan",
        "plc",
        "friday",
        "lost",
        "bid",
        "delay",
        "upcoming",
        "trial",
        "class",
        "action",
        "lawsuit",
        "claiming",
        "suppressed",
        "generic",
        "competition",
        "ulcerative",
        "colitis",
        "drug",
        "asacol",
        "district",
        "judge",
        "denise",
        "casper",
        "boston",
        "denied",
        "allergan",
        "request",
        "stay",
        "case",
        "pending",
        "appeal",
        "november",
        "decision",
        "certify",
        "class",
        "health",
        "plan",
        "indirect",
        "purchaser",
        "drug",
        "read",
        "full",
        "story",
        "westlawnext",
        "practitioner",
        "insight",
        "click"
    ]
}